Updated on 17 September 2026
ELEMENTARy - funding opportunities
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
About
ELEMENTARY offers a proprietary preclinical screening platform built on patient-derived tumor models specifically developed for rare endocrine cancers, a disease area currently underserved by standard drug discovery pipelines. The platform is designed to identify compounds with direct clinical translatability, significantly reducing the gap between preclinical screening and early-phase clinical application. The platform is currently in validation phase on MTC, with a clear development roadmap toward the broader NET space.
ELEMENTARY is seeking pre-seed investment to complete the platform validation phase on MTC and progress toward more rare endocrine cancers.
Stage
- Pre-seed funding | Idea validation
Similar opportunities
Product
Elisa Stellaria Grassi
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
Service
ELEMENTARY - compounds validation
Elisa Stellaria Grassi
Associate Researcher at Istituto Auxologico Italiano
Milan, Italy
Investment
iRASP - a novel platform to design efficacious cancer targeted immunotherapies
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy